Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2022-03-04 00:00:00 ET · period of report 2022-03-03 · accession 0001415889-22-002548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-04 | 2022-03-03 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-03-04 | 2022-03-03 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $174.12 | -6,000 | 36.4K | -14% | -$1.04M |
| D | 2022-03-04 | 2022-03-03 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 58.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | M | A | 6,000 | $111.00 | 42,369 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-03 | S | D | 5,600 | $174.08 | 36,769 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $173.58 to $174.455. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-03-03 | S | D | 400 | $174.70 | 36,369 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $174.59 to $174.895. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Stock Options | 2022-03-03 | M | D | 6,000 | $0.00 | 58,552 | D | $111.00 · 2021-03-15 to 2028-03-15 | 6,000 Common Stock | (F4) These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profits during 2018-2020, and vested on March 15, 2021 |